Cargando…
Identification of potential neuroprotective compound from Ganoderma lucidum extract targeting microtubule affinity regulation kinase 4 involved in Alzheimer's disease through molecular dynamics simulation and MMGBSA
OBJECTIVE: Alzheimer's disease (AD) is one of the most prevalent neurological ailments, affecting around 50 million individuals globally. The condition is characterized by nerve cell damage due to the formation of amyloid‐beta plaques and neurofibrillary tangles. Only a few US Food and Drug Adm...
Autores principales: | Ahmad, Faizan, Singh, Gagandeep, Soni, Hemant, Tandon, Smriti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242270/ https://www.ncbi.nlm.nih.gov/pubmed/37287673 http://dx.doi.org/10.1002/agm2.12232 |
Ejemplares similares
-
Triterpenes and Aromatic Meroterpenoids with Antioxidant Activity and Neuroprotective Effects from Ganoderma lucidum
por: Wang, Cuifang, et al.
Publicado: (2019) -
Neuroprotective effect of pretreatment with ganoderma lucidum in cerebral ischemia/reperfusion injury in rat hippocampus
por: Zhang, Wangxin, et al.
Publicado: (2014) -
Neuroprotective effects of ganoderma lucidum polysaccharides against oxidative stress-induced neuronal apoptosis
por: Sun, Xin-zhi, et al.
Publicado: (2017) -
GC-based chemoprofile of lipophilic compounds in Altaian Ganoderma lucidum sample
por: Shevelev, Oleg B., et al.
Publicado: (2018) -
Triterpenoids from the spores of Ganoderma lucidum
por: Ma, Bingji, et al.
Publicado: (2011)